ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Metroid Gets An Unofficial 8-Bit Prequel Courtesy Of Dedicated Fans – WWG

WWGMetroid Gets An Unofficial 8-Bit Prequel Courtesy Of Dedicated FansWWGPirates seized a capsule said to contain a newly discovered life form in a state of suspended animation. Rogue Dawn surrounds these events that led up to the theft of the capsule … Continue reading

2017-02-02 Michael Zand NEWS

Dr. Schoenfeld on Low-Dose Radiation Plus Immunotherapy in Head and Neck Cancer – OncLive

Dr. Schoenfeld on Low-Dose Radiation Plus Immunotherapy in Head and Neck CancerOncLiveJonathan D. Schoenfeld, MD, MPhil, MPH, director, melanoma radiation oncology, physician, assistant professor of radiation oncology, Harvard Medical School, Dana-Farb… Continue reading

2017-02-02 Michael Zand NEWS

Immunotherapy Tops Cancer Advances Again – MedPage Today

Continue reading

2017-02-02 Michael Zand NEWS

Immunotherapy Tops Cancer Advances Again – MedPage Today

Immunotherapy Tops Cancer Advances Again
MedPage Today
The transformative effect of immunotherapy on cancer remained the top cancer advance for the second consecutive year, according to the American Society of Clinical Oncology (ASCO). “Immunotherapy 2.0″ topped all other advances during 2016, according …
ASCO Report Names Advanced of the Year: Immunotherapy 2.0LWW Journals (blog)

all 3 news articles »

Continue reading

2017-02-02 Michael Zand NEWS

Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing Drug – Yahoo Finance

Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing DrugYahoo Finance2, 2017 /PRNewswire/ — Neovia Oncology, (Beijing, Taiwan, & Seattle), has begun its first Phase 1 clinical trial for its lead cancer drug NEV-801, a novel, m… Continue reading

2017-02-02 Michael Zand NEWS

Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing Drug – Yahoo Finance

Neovia Enrolls First Patient in Cancer Trial for Immunotherapy Enhancing DrugYahoo Finance2, 2017 /PRNewswire/ — Neovia Oncology, (Beijing, Taiwan, & Seattle), has begun its first Phase 1 clinical trial for its lead cancer drug NEV-801, a novel, m… Continue reading

2017-02-02 Michael Zand NEWS

Adrift in Sea of Moving Portraits, Bill Viola Captures Human Experience – The Washington Diplomat

Adrift in Sea of Moving Portraits, Bill Viola Captures Human ExperienceThe Washington DiplomatSurrounded by these life-size figures, I began to feel like I was underwater as well, floating silently with them. I felt both a sense of anticipation and tim… Continue reading

2017-02-01 Michael Zand NEWS

BioMarin Pharma (BMRN) Reports PRIME Regulatory Support for BMN 270 Gene Therapy in Hemophilia A – StreetInsider.com

Immunotherapy Tops Cancer Advances Again
MedPage Today
The transformative effect of immunotherapy on cancer remained the top cancer advance for the second consecutive year, according to the American Society of Clinical Oncology (ASCO). “Immunotherapy 2.0″ topped all other advances during 2016, according …
ASCO Report Names Advanced of the Year: Immunotherapy 2.0LWW Journals (blog)

all 3 news articles »

Continue reading

2017-02-01 Michael Zand NEWS
  • 1
  • …
  • 2,152
  • 2,153
  • 2,154
  • 2,155
  • 2,156
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

StreetInsider.com

BioMarin Pharma (BMRN) Reports PRIME Regulatory Support for BMN 270 Gene Therapy in Hemophilia A
StreetInsider.com
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced today that the European Medicines Agency (EMA) has granted access to its Priority Medicines (PRIME) regulatory initiative for the company’s investigational gene therapy treatment for severe …

and more »